257 related articles for article (PubMed ID: 24624866)
1. [Structural and functional analysis of tumor genomes and the development of test systems for early diagnosis, prognosis and cancer therapy optimization].
Zaletaev DV; Strel'nikov VV; Nemtsova MV; Babenko OV; Kuznetsova EB; Zemliakova VV; Kekeeva TV; Mikhaĭlenko DS; Tanas AS; Rudenko VV; Babaian AIu; Alekseeva EA; Simonova OA
Vestn Ross Akad Med Nauk; 2013; (9):7-14. PubMed ID: 24624866
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic and prognostic epigenetic biomarkers in cancer.
Costa-Pinheiro P; Montezuma D; Henrique R; Jerónimo C
Epigenomics; 2015; 7(6):1003-15. PubMed ID: 26479312
[TBL] [Abstract][Full Text] [Related]
3. The potential of DNA modifications as biomarkers and therapeutic targets in oncology.
Jankowska AM; Millward CL; Caldwell CW
Expert Rev Mol Diagn; 2015; 15(10):1325-37. PubMed ID: 26394702
[TBL] [Abstract][Full Text] [Related]
4. Input of molecular analysis in medical management of primary brain tumor patients.
Idbaih A; Duran-Peña A; Bonnet C; Ducray F
Rev Neurol (Paris); 2015; 171(6-7):457-65. PubMed ID: 26026669
[TBL] [Abstract][Full Text] [Related]
5. Whole-Exome Sequencing of Metastatic Cancer and Biomarkers of Treatment Response.
Beltran H; Eng K; Mosquera JM; Sigaras A; Romanel A; Rennert H; Kossai M; Pauli C; Faltas B; Fontugne J; Park K; Banfelder J; Prandi D; Madhukar N; Zhang T; Padilla J; Greco N; McNary TJ; Herrscher E; Wilkes D; MacDonald TY; Xue H; Vacic V; Emde AK; Oschwald D; Tan AY; Chen Z; Collins C; Gleave ME; Wang Y; Chakravarty D; Schiffman M; Kim R; Campagne F; Robinson BD; Nanus DM; Tagawa ST; Xiang JZ; Smogorzewska A; Demichelis F; Rickman DS; Sboner A; Elemento O; Rubin MA
JAMA Oncol; 2015 Jul; 1(4):466-74. PubMed ID: 26181256
[TBL] [Abstract][Full Text] [Related]
6. A DNA hypermethylation profile reveals new potential biomarkers for prostate cancer diagnosis and prognosis.
Ashour N; Angulo JC; Andrés G; Alelú R; González-Corpas A; Toledo MV; Rodríguez-Barbero JM; López JI; Sánchez-Chapado M; Ropero S
Prostate; 2014 Sep; 74(12):1171-82. PubMed ID: 24961912
[TBL] [Abstract][Full Text] [Related]
7. Integrative genomic data mining for discovery of potential blood-borne biomarkers for early diagnosis of cancer.
Yang Y; Pospisil P; Iyer LK; Adelstein SJ; Kassis AI
PLoS One; 2008; 3(11):e3661. PubMed ID: 18987750
[TBL] [Abstract][Full Text] [Related]
8. Integrated proteo-genomic approach for early diagnosis and prognosis of cancer.
Shukla HD; Mahmood J; Vujaskovic Z
Cancer Lett; 2015 Dec; 369(1):28-36. PubMed ID: 26276717
[TBL] [Abstract][Full Text] [Related]
9. Micro-RNAs: The new potential biomarkers in cancer diagnosis, prognosis and cancer therapy.
Mansoori B; Mohammadi A; Shirjang S; Baradaran B
Cell Mol Biol (Noisy-le-grand); 2015 Oct; 61(5):1-10. PubMed ID: 26475381
[TBL] [Abstract][Full Text] [Related]
10. Neoadjuvant Model in Cancer Treatment: From Clinical Opportunity to Health-Care Utility.
Generali D; Fox SB; Cristofanilli M; Bianchini G; Zambelli A; Hatzis C; Barberis M; Tarricone R; Bottini A; Rossi C; Tringali M
J Natl Cancer Inst Monogr; 2015 May; 2015(51):1-3. PubMed ID: 26063875
[TBL] [Abstract][Full Text] [Related]
11. Regularly methylated novel pro-apoptotic genes associated with recurrence in transitional cell carcinoma of the bladder.
Christoph F; Weikert S; Kempkensteffen C; Krause H; Schostak M; Miller K; Schrader M
Int J Cancer; 2006 Sep; 119(6):1396-402. PubMed ID: 16642478
[TBL] [Abstract][Full Text] [Related]
12. [Possibilities of molecular diagnosis of renal cell carcinoma].
Junker K
Aktuelle Urol; 2014 Sep; 45(5):370-3. PubMed ID: 25230022
[TBL] [Abstract][Full Text] [Related]
13. Estimating cancer survival and clinical outcome based on genetic tumor progression scores.
Rahnenführer J; Beerenwinkel N; Schulz WA; Hartmann C; von Deimling A; Wullich B; Lengauer T
Bioinformatics; 2005 May; 21(10):2438-46. PubMed ID: 15705654
[TBL] [Abstract][Full Text] [Related]
14. The clinical relevance of circulating, exosomal miRNAs as biomarkers for cancer.
Schwarzenbach H
Expert Rev Mol Diagn; 2015; 15(9):1159-69. PubMed ID: 26202667
[TBL] [Abstract][Full Text] [Related]
15. Predicting Prognosis in Chronic Lymphocytic Leukemia in the Contemporary Era.
Nabhan C; Raca G; Wang YL
JAMA Oncol; 2015 Oct; 1(7):965-74. PubMed ID: 26181643
[TBL] [Abstract][Full Text] [Related]
16. Development of Castration Resistant Prostate Cancer can be Predicted by a DNA Hypermethylation Profile.
Angulo JC; Andrés G; Ashour N; Sánchez-Chapado M; López JI; Ropero S
J Urol; 2016 Mar; 195(3):619-26. PubMed ID: 26551297
[TBL] [Abstract][Full Text] [Related]
17. Distinctive microRNAs in esophageal tumor: early diagnosis, prognosis judgment, and tumor treatment.
Li SQ; Chen FJ; Cao XF
Dis Esophagus; 2013 Apr; 26(3):288-98. PubMed ID: 22458808
[TBL] [Abstract][Full Text] [Related]
18. [Markers for non-invasive molecular genetic diagnosis of oncourological diseases].
Mikhaĭlenko DS; Perepechin DV; Apolikhin OI; Efremov GD; Sivkov AV
Urologiia; 2014; (5):116-20. PubMed ID: 25807773
[TBL] [Abstract][Full Text] [Related]
19. Brave-ish New World--What's Needed to Make Precision Oncology a Practical Reality.
MacConaill LE; Lindeman NI; Rollins BJ
JAMA Oncol; 2015 Oct; 1(7):879-80. PubMed ID: 26181886
[No Abstract] [Full Text] [Related]
20. Non-invasive, serum DNA pregnancy testing leading to incidental discovery of cancer: a good thing?
Prasad V
Eur J Cancer; 2015 Nov; 51(16):2272-4. PubMed ID: 26278647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]